MedTrace Logo

Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study

NCT00137956 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2009-08-18

No results posted yet for this study

Summary

The purpose of the VENT Cost-Effectiveness Sub-Study is to gather healthcare utilization and quality of life information on patients enrolled in the VENT study in order to analyze the relative cost-effectiveness of the endobronchial valve implant procedure.

Conditions

Interventions

DEVICE

Emphasys Endobronchial Valve (EBV) Device and Procedure

Sponsors & Collaborators

  • Emphasys Medical

    lead INDUSTRY

Principal Investigators

  • Robert Kaplan, PhD · UCLA School of Public Health, UCSD Health Outcomes Assessment Program (HOAP)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00137956 on ClinicalTrials.gov